Genprex recently announced that independent researchers found that company’s TUSC2 (tumor suppressor candidate 2) prevented tumor growth in triple-negative breast cancer (TNBC). These independent researchers have no affiliation with Genprex. Genprex takes a deeper dive into the data of the study to provide analysis and a better understanding of what the study found and what it […]